NAD+
Cellular Energy & Metabolic Science
WELL ESTABLISHED
STILL BEING STUDIED
LIMITED EVIDENCE
What Is NAD+?
Nicotinamide adenine dinucleotide, commonly called NAD+, is a molecule naturally present in the body's cells.
It plays an essential role in cellular energy metabolism, redox reactions, DNA-related processes, and signaling pathways involving enzymes such as sirtuins and PARPs. Researchers are particularly interested in NAD+ because changes in NAD+ metabolism have been associated with aging and several areas of metabolic health.
Important: NAD+ is not a peptide. It is included in this educational library because of its close relationship to cellular metabolism, mitochondrial function, healthy-aging research, and other areas commonly discussed alongside peptide science.
Why Are Researchers Interested?
Research interest in NAD+ centers largely on its fundamental role in cellular metabolism. Scientists are investigating whether influencing NAD+ availability may affect areas including:
Much of the excitement surrounding NAD+ comes from laboratory and animal research. Human research has expanded considerably, but results relating to meaningful health outcomes remain mixed.
What The Research Suggests
NAD+ Can Be Influenced Biologically
Human studies using NAD+ precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have demonstrated that NAD-related biomarkers can be increased in blood and, in some studies, certain tissues.
This provides evidence that the NAD metabolic system can be influenced in humans.
Aging Is an Important Area of Research
Some human studies have identified age-associated differences in NAD+ and related metabolites, and declining NAD availability has been proposed as one possible contributor to age-related biological changes.
More recent scientific reviews caution that the relationship between NAD+ and human aging is more complicated than is sometimes portrayed in consumer wellness marketing. Evidence of age-related decline varies depending on tissue, population, and measurement method.
NAD+ Precursors Have More Human Research Than IV NAD+
A very important distinction is the difference between NAD+ itself and NAD+ precursors such as NR and NMN. Human clinical research is substantially more developed for oral NAD+ precursors.
A 2026 systematic review found that NR and NMN consistently affected NAD-related biomarkers, but effects on functional, metabolic, vascular, and other health outcomes were inconsistent or limited to particular endpoints.
Evidence At A Glance
Established Biology
NAD+ is essential to normal cellular metabolism and numerous biochemical pathways.
Ability to Raise NAD-Related Biomarkers
NR and NMN have demonstrated the ability to increase NAD-related biomarkers in human studies.
Anti-Aging / Longevity Benefits
Human evidence does not currently demonstrate broad, consistent anti-aging or longevity benefits.
IV NAD+ Wellness Benefits
Well-controlled human outcomes research on IV NAD+ itself remains notably limited.
Safety & Limitations
NAD+ is naturally present in the body, but this does not mean that every method of administering additional NAD+ is automatically safe or clinically established.
The FDA has specifically warned compounders about the use of inappropriate ingredients when producing sterile NAD+ injectable products. FDA reported adverse events following compounded NAD+ injections including severe chills, shaking, vomiting, and fatigue, with some patients requiring medical treatment. The agency noted that some reactions were consistent with excessive endotoxin exposure and emphasized the importance of pharmaceutical-quality ingredients for sterile compounding.
This issue illustrates an important distinction: the biological role of NAD+ and the safety of a particular compounded injectable product are not the same question. Product quality, sterility, sourcing, formulation, route of administration, and clinical circumstances all matter.
Regulatory Status
Is NAD+ FDA-Approved for Anti-Aging or Wellness?
No. NAD+ itself is not FDA-approved as an anti-aging, longevity, energy, or general wellness treatment.
Compounded medications are also not FDA-approved products; FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
What About Compounding?
As of FDA's April 22, 2026 update, Nicotinamide Adenine Dinucleotide appears in 503A Category 1 — Bulk Drug Substances Under Evaluation. That designation should not be confused with FDA approval.
The rules are different for FDA-registered 503B outsourcing facilities. In a January 2026 warning letter, FDA stated that NAD+ was not on the applicable 503B bulks list and therefore did not qualify under that facility's cited circumstances.
Regulatory Status: Evolving — NAD+ is not FDA-approved for anti-aging or general wellness indications. Compounding status depends on the applicable federal compounding framework and other legal requirements. Regulatory status may change over time.
NAD+ vs. NAD+ Precursors
Evidence involving NR or NMN should not automatically be presented as evidence that IV NAD+ produces the same effects. Different compounds and routes of administration require their own evidence.
NAD+
The molecule directly involved in cellular metabolism.
NR — Nicotinamide Riboside
A vitamin B3-related precursor the body can use in NAD+ metabolism.
NMN — Nicotinamide Mononucleotide
Another NAD+ precursor studied as a method of increasing NAD-related metabolites.
Why the Difference Matters: Evidence involving NR or NMN should not automatically be presented as evidence that IV NAD+ produces the same effects. Different compounds and routes of administration require their own evidence.
Research & Publications
2026 Systematic Review — NAD+ Supplementation, Anti-Aging & Wellness
Ageing Research Reviews — 2026
Reviewed 113 human and animal intervention studies and concluded that NAD+ augmentation clearly affects biology, while clinical effectiveness for anti-aging and wellness outcomes remains inconclusive.
View on PubMedNAD+ Precursors and Human Aging
Nature Metabolism — 2025
Reviews human evidence surrounding age-associated NAD+ changes and NAD+ precursor supplementation, highlighting both scientific potential and substantial unanswered questions.
View on PubMedNAD+ in Aging Biology: Potential Applications and Many Unknowns
Endocrine Reviews — 2023
A detailed review of NAD+ biology, clinical pharmacology, cardiometabolic research, and the limitations of current human evidence.
View on PubMedHuman NMN Study
Randomized, Placebo-Controlled Trial
A randomized, placebo-controlled study examining whether oral NMN could increase NAD+ levels in healthy older men.
View on PubMedHuman Nicotinamide Riboside Study
Randomized Crossover Trial
A randomized crossover study showing that NR increased NAD+ metabolism in healthy middle-aged and older adults.
View ResearchFDA — NAD+ Injectable Compounding Safety Notice
U.S. Food and Drug Administration
FDA information concerning sterile compounded NAD+ products, ingredient quality, and reported adverse events.
View FDA ResourceNAD+ is an active area of scientific research, but established biology should not be confused with established treatment benefit.
Evidence involving NAD+ precursors, animal research, laboratory studies, and direct administration of NAD+ should be evaluated separately.
This page is provided for educational purposes only. NAD+ is not offered for sale, prescription, or distribution through this website.